FindTrial
Sign In

Antabuse in severe alcoholism: an open controlled study

Antabuse in severe alcoholism: an open controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-004921-27-DK
Enrollment
Unknown
Registered
2006-11-29
Start date
2006-12-15
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism MedDRA version: 8.1 Level: LLT Classification code 10001639 Term: Alcoholism

Interventions

Trade Name: Antabuse Pharmaceutical Form: Tablet

Sponsors

Psykiatrisk Center Gentofte
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age 18 - 70 ICD 10 diagnoses of alcoholdependence (F10.2) and alcoholwithdrawal (F10.3) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Schizophrenia dementia bipolar disorder dependence on other psychoactive drugs of abuse pregnancy

Design outcomes

Primary

MeasureTime frame
Main Objective: To test whether disulfiram (antabuse) can prevent newly detoxified alcoholics from drinking alcohol in 6 months compared to a group which do not receive medication;Secondary Objective: ;Primary end point(s): Sobriety during 6 months—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026